Company Tryp Therapeutics Inc. OTC Markets
Equities
TRYPF
CA89854F1062
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0562 USD | +32.24% | +14.69% | +64.81% |
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 439,423,066 | 392,449,835 ( 89.31 %) | 0 | 89.31 % |
Company contact information
Tryp Therapeutics, Inc.
1665 Ellis Street Suite 301
V1Y 2B3, Kelowna
+833-811-8797
http://tryptherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+33.01% | 50.85B | |
+1.06% | 42.82B | |
+48.94% | 42.03B | |
-4.22% | 29.55B | |
+11.05% | 26.11B | |
-21.57% | 19.13B | |
+8.35% | 13.05B | |
+27.33% | 12.16B | |
+23.45% | 12.08B |
- Stock Market
- Equities
- TYP Stock
- TRYPF Stock
- Company Tryp Therapeutics Inc.